Clinical Trial Update: An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®

View source ↗

Summary

An observational study evaluating the safety and tolerability of prolonged thrombosis prophylaxis with Fragmin (dalteparin) in patients at risk for venous throm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)

Snippet

Sponsor: Pfizer | Conditions: Venous Thromboembolism | Status: COMPLETED | Results posted: 2012-02-13